Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?

Krzysztof Banaszkiewicz, Emilia J Sitek, Monika Rudzińska, Witold Sołtan, Jarosław Sławek, Andrzej Szczudlik, Krzysztof Banaszkiewicz, Emilia J Sitek, Monika Rudzińska, Witold Sołtan, Jarosław Sławek, Andrzej Szczudlik

Abstract

The aim of this study was to identify determinants of functional disability, patient's quality of life (QoL) and caregivers' burden in Huntington's disease (HD). Eighty HD patients participated in the study. Motor and behavioral disturbances as well as cognitive impairment were assessed using motor, behavioral and cognitive parts of the Unified Huntington Disease Rating Scale (UHDRS); Hamilton Depression Rating Scale was used to assess depression. Disability, health-related QoL and the impact of the disease on the caregivers were assessed using the following methods: UHDRS Functional Assessment Score, SF-36 Scale and Caregiver Burden Inventory. Multiple regression analysis showed that motor disturbances, cognitive impairment, apathy and disease duration were the independent predictors of disability. Depression and cognitive disturbances were the determinants of patient's QoL, while motor disturbances and depression were the predictors of the caregiver burden. Patient's disability and QoL as well as caregivers' burden should be taken into consideration while planning treatment strategy and the results of the present study show that the predictors of those treatment targets are different.

References

    1. Aubeeluck A, Buchanan H. The Huntington’s disease quality of life battery for carers: reliability and validity. Clin Genet. 2007;71(5):434–445. doi: 10.1111/j.1399-0004.2007.00784.x.
    1. Blekher T, Weaver MR, Marshall J, Hui S, Jackson JG, Stout JC, et al. Visual scanning and cognitive performance in prediagnostic and early-stage Huntington’s disease. Mov Disord. 2009;24(4):533–540. doi: 10.1002/mds.22329.
    1. D’Amelio M, Terruso V, Palmeri B, Di Benedetto N, Famoso G, Cottone P, et al. Predictors of caregiver burden in partners of patients with Parkinson’s disease. Neurol Sci. 2009;30(2):171–174. doi: 10.1007/s10072-009-0024-z.
    1. Hamilton JM, Salmon DP, Corey-Bloom J, Gamst A, Paulsen JS, Jerkins S, et al. Behavioural abnormalities contribute to functional decline in Huntington’s disease. J Neurol Neurosurg Psychiatry. 2003;74(1):120–122. doi: 10.1136/jnnp.74.1.120.
    1. Hartelius L, Jonsson M, Rickeberg A, Laakso K. Communication and Huntington’s disease: qualitative interviews and focus groups with persons with Huntington’s disease, family members, and carers. Int J Lang Commun Disord. 2010;45(3):381–393. doi: 10.3109/13682820903105145.
    1. Hayden MR, Ehrlich R, Parker H, Ferera SJ. Social perspectives in Huntington’s chorea. S Afr Med J. 1980;58:201–203.
    1. Ho AK, Gilbert AS, Mason SL, Goodman AO, Barker RA. Health-related quality of life in Huntington’s disease: which factors matter most? Mov Disord. 2009;24(4):574–578. doi: 10.1002/mds.22412.
    1. Huntington Study Group Unified Huntington’s Disease Rating Scale: reliability and consistency. Mov Disord. 1996;11(2):136–142. doi: 10.1002/mds.870110204.
    1. Karlsen KH, Larsen JP, Tandberg E, Maland JG. Quality of life measurements in patients with Parkinson’s disease: a community-based study. Eur J Neurol. 1998;5(5):443–450. doi: 10.1046/j.1468-1331.1998.550443.x.
    1. Karlsen KH, Tandberg E, Arsland D, Larsen JP. Health related quality of life in Parkinson’s disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry. 2000;69(5):584–589. doi: 10.1136/jnnp.69.5.584.
    1. Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Huntington Study Group et al. Rate of functional decline in Huntington’s disease. Neurology. 2000;54(2):452–458. doi: 10.1212/WNL.54.2.452.
    1. McCabe MP, Firth L, O’Connor E. A comparison of mood and quality of life among people with progressive neurological illnesses and their caregivers. J Clin Psychol Med Settings. 2009;16(4):355–362. doi: 10.1007/s10880-009-9168-5.
    1. Novak M, Guest CI. Application of a multidimensional Caregiver Burden Inventory. Gerontologist. 1989;29:798–803. doi: 10.1093/geront/29.6.798.
    1. Orth M, European Huntington’s Disease Network. Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB. Observing Huntington’s disease: the European Huntington’s Disease Network’s Registry. J Neurol Neurosurg Psychiatry. 2011;82(12):1409–1412. doi: 10.1136/jnnp.2010.209668.
    1. Razani J, Kakos B, Orieta-Barbalace C, Wong JT, Casas R, Lu P, et al. Predicting caregiver burden from daily functional abilities of patients with mild dementia. J Am Geriatr Soc. 2007;55(9):1415–1420. doi: 10.1111/j.1532-5415.2007.01307.x.
    1. Ready RE, Mathews M, Leserman A, Paulsen JS. Patient and caregiver quality of life in Huntington’s disease. Mov Disord. 2008;23(5):721–726. doi: 10.1002/mds.21920.
    1. Roscoe LA, Corsentino E, Watkins S, McCall M, Sanchez-Ramos J. Well-being of family caregivers of persons with late-stage Huntington’s disease: lessons in stress and coping. Health Commun. 2009;24(3):239–248. doi: 10.1080/10410230902804133.
    1. Sitek EJ, Sołtan W, Wieczorek D, Schinwelski M, Robowski P, Reilmann R, Guzińska K, Harciarek M, Krysa W, Sławek J. Self-awareness of motor dysfunction in patients with Huntington’s disease in comparison to Parkinson’s disease and cervical dystonia. J Int Neuropsychol Soc. 2011;17(5):788–795. doi: 10.1017/S1355617711000725.
    1. Snowden JS, Craufurd D, Griffiths HL, Neary D. Awareness of involuntary movements in Huntington disease. Arch Neurol. 1998;55(6):801–805. doi: 10.1001/archneur.55.6.801.
    1. Stern R, Eldridge R. Attitudes of patients and their relatives to Huntington’s disease. J Med Genet. 1975;12(3):217–223. doi: 10.1136/jmg.12.3.217.
    1. Veenhuizen RB, Tibben A. Coordinated multidisciplinary care for Huntington’s disease: an outpatient department. Brain Res Bull. 2009;80(4–5):192–195. doi: 10.1016/j.brainresbull.2009.06.017.

Source: PubMed

Подписаться